GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+20.32%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$277M
AUM Growth
+$277M
(+4.8%)
Cap. Flow
-$4.64M
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
51.48%
Holding
69
New
14
Increased
24
Reduced
14
Closed
11
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$6.96M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
$6.89M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$5.78M |
| 4 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$4.01M |
| 5 |
Akero Therapeutics
AKRO
|
$3.97M |
Top Sells
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$8.4M |
| 2 |
Axsome Therapeutics
AXSM
|
$8.26M |
| 3 |
Pfizer
PFE
|
$8.16M |
| 4 |
Johnson & Johnson
JNJ
|
$7.75M |
| 5 |
TG Therapeutics
TGTX
|
$6.83M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
26
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $3.45M | 1.14% |
201,197
+1,197
| +0.6% | +$20.4K |
|
27
Zentalis Pharmaceuticals
ZNTL
$123M
| $2.82M | 0.93% |
+100,000
| New | +$2.82M |
|
|
KRTX
28
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.71M | 0.89% |
12,500
-5,000
| -29% | -$1.08M |
|
29
Tarsus Pharmaceuticals
TARS
$2.44B
| $2.71M | 0.89% |
150,000
+70,000
| +88% | +$1.26M |
|
30
Amicus Therapeutics
FOLD
$2.42B
| $2.51M | 0.83% |
200,000
-275,000
| -58% | -$3.45M |
|
31
Astria Therapeutics
ATXS
$394M
| $2.5M | 0.83% |
300,173
-149,827
| -33% | -$1.25M |
|
32
uniQure
QURE
$954M
| $2.46M | 0.81% |
215,000
-160,000
| -43% | -$1.83M |
|
33
Krystal Biotech
KRYS
$4.35B
| $2.35M | 0.78% |
+20,000
| New | +$2.35M |
|
|
VRNA
34
Verona Pharma
VRNA
$9.18B
| $2.33M | 0.77% |
+110,000
| New | +$2.33M |
|
35
Phathom Pharmaceuticals
PHAT
$843M
| $2.21M | 0.73% |
+154,250
| New | +$2.21M |
|
|
FUSN
36
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.93M | 0.64% |
412,699
+62,699
| +18% | +$293K |
|
|
IMGN
37
DELISTED
Immunogen Inc
IMGN
| $1.89M | 0.62% |
100,000
-24,977
| -20% | -$471K |
|
38
PMV Pharmaceuticals
PMVP
$82.1M
| $1.76M | 0.58% |
+280,981
| New | +$1.76M |
|
|
WHWK
39
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $1.71M | 0.56% |
250,000
+100,000
| +67% | +$684K |
|
40
Arcus Biosciences
RCUS
$1.24B
| $1.52M | 0.5% |
75,000
| – | – |
|
41
Rocket Pharmaceuticals
RCKT
$358M
| $1.49M | 0.49% |
+75,000
| New | +$1.49M |
|
42
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.41M | 0.46% |
200,000
-75,000
| -27% | -$528K |
|
|
MORF
43
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.15M | 0.38% |
+20,000
| New | +$1.15M |
|
|
INBX
44
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $909K | 0.3% |
+35,000
| New | +$909K |
|
|
SWTX
45
DELISTED
SpringWorks Therapeutics
SWTX
| $723K | 0.24% |
27,578
| – | – |
|
46
BridgeBio Pharma
BBIO
$9.91B
| $722K | 0.24% |
42,000
+17,000
| +68% | +$292K |
|
47
Avidity Biosciences
RNA
$6.12B
| $721K | 0.24% |
65,000
-60,000
| -48% | -$665K |
|
48
Iovance Biotherapeutics
IOVA
$800M
| $704K | 0.23% |
100,000
-900,000
| -90% | -$6.34M |
|
49
PTC Therapeutics
PTCT
$4.41B
| $678K | 0.22% |
+16,675
| New | +$678K |
|
50
Roivant Sciences
ROIV
$8.6B
| $645K | 0.21% |
+64,000
| New | +$645K |
|